🦉 Is CRISPR Therapeutics the NVIDIA of gene editing?

‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  Unsubscribe Your Evening Recap for Monday, February 26th Equity markets started the week on uncertain footing as the focus shifted away from NVIDIA and AI toward economic data. A full slate of data is due out, including the January read of the PCE price index. The PCE price index is expected to show a sequential acceleration to align with the latest CPI data, news that is unlikely to spur risk-on appetite. Hot inflation will keep the FOMC's policy tight until later in the year, jeopardizing this year's earnings outlook. The market has its hopes pinned on an interest rate cut in the first half, and it is becoming less and less likely. The CME FedWatch Tool shows a slim chance for a single 25 basis point cut by June and only a 50/50 chance for two by July. Because the 2nd-half earnings outlook depends on rates falling, a hot inflation read could have an outsized impact on the market. As it is, the S&P 500 is well above critical support and the 150-day moving average, setting it up for a high-single-digit decline when it comes. Featured: HUGE BUY ALERT: Move Fast, Musk… (Stansberry Research) The Night Owl is an evening newsletter published by The Early Bird and powered by MarketBeat. The Night Owl covers top stories on the stock market and outlook on interesting stocks. If you give a hoot about the market, read your copy every Tuesday, Thursday, and Sunday evening.   American Consumer News, LLC dba MarketBeat 345 N Reid Place, Suite 620, Sioux Falls, SD 57103. contact@marketbeat.com   Unsubscribe View as a Web Page   Today's Bonus Content: Jeff Bezos Backs "Drug Smuggler" to Fight Alzheimer's